None listed
Conditions
Interventions
Group A: TAPB group:TAPB formulation was ropivacaine
Group B: dexmedetomidine group:TAPB formula was ropivacaine combined with dexmedetomidine
Group C: dexamethasone group:TAPB formula was ropivacaine combined with dexamethasone
Group D: morphine group:TAPB formulation was ropivacaine combined with morphine.
Sponsors
The Third People's Hospital of Shenzhen
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: Age 18-65 years old, ASA Grade I to II, BMI 18-30kg /m^2
Exclusion criteria
Exclusion criteria: History of allergy to narcotic drugs (such as ropivacaine, dexmedetomidine, dexamethasone, etc.) or other serious drugs; Endocrine diseases or diseases of the immune system; Preoperative treatment for endocrine disruption (such as radiotherapy or chemotherapy); The expected operation time is greater than 4 hours; Puncture site infection; Severe coagulation dysfunction; Preoperatively treated with opioids or have a mental illness that affects your pain score; Severe organ dysfunction before surgery; Combined with severe arrhythmia; The preoperative and postoperative evaluations could not be completed or the treating physician considered it unsuitable to participate in the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Resting visual analog score; | — |
Secondary
| Measure | Time frame |
|---|---|
| Total use of sufentanil after surgery;Plasma concentrations of inflammatory factors; | — |
Countries
China
Contacts
Public ContactWu Qiang
The Third People's Hospital of Shenzhen
Outcome results
None listed